Advantech

Aures Technologies specializes in importing and marketing computer terminals and equipment. The group's activity is organized around 2 families of product and services: outlets computer terminals and systems: ticket printers, cash registers, screens, bar code readers, etc., intended primarily for businesses, supermarkets, hotels, and restaurants.

Elite's seven-axis collaborative robot uses the latest deep neural network (DNN) technology to identify irregularly shaped objects and accurately capture them. Through the fusion of 2D and 3D data, the accuracy requirements of the depth vision sensor are reduced, the success rate of the capture is improved, the versatility of the grabbing system is enhanced, and the hybrid object capture is supported. The system can be widely used in 3C, logistics, retail, catering and other industries.

CureGenetics is a biotechnology company focused on developing innovative medicines and molecular diagnostics aimed at treating cancers and genetic diseases. The company specializes in research and development of gene editing technologies and delivery platforms, which are designed to provide advanced treatment solutions. By leveraging cutting-edge applications, CureGenetics seeks to address the challenges posed by these complex medical conditions through next-generation therapeutic approaches.

Innoforce Pharmaceuticals Co., Ltd is a biopharmaceutical company based in Hangzhou, China, founded in 2018. The company specializes in the development and commercialization of innovative biomedicines, including cell and gene therapies, medicines, and antibodies. Innoforce also operates biologic process development laboratories and offers end-to-end contract development and manufacturing services (CDMO) tailored to support biotech enterprises in their research and development and manufacturing efforts. Through its comprehensive services, Innoforce aids clients in bringing their biopharmaceutical products to market efficiently.

Ablaze Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing targeted radiotherapy (TRT) treatments for cancer patients. The company aims to introduce innovative TRT products to the Chinese market, leveraging the founders' extensive experience and networks in cross-border product development and deal-making. By focusing on advanced therapeutic solutions, Ablaze Pharmaceuticals seeks to improve the outcomes and quality of life for cancer patients in China.

Zhimeng is also actively developing novel small molecule drugs to treat neurological diseases, such as epilepsy, pains and strokes.

Boan Biotech is a fully integrated biopharmaceutical company specializing in the development, manufacture, and commercialization of therapeutic antibodies. The company focuses on several key therapeutic areas, including oncology, metabolism, autoimmunity, and ophthalmology. While it primarily generates revenue from customers in Mainland China, Boan Biotech aims to expand its reach globally. The company is committed to delivering high-quality biologics to address unmet medical needs in these critical fields.

Zhuanzhuan is an online marketplace that facilitates the buying and selling of secondhand goods, providing a platform for users to trade items efficiently. Established in November 2015 and headquartered in China, Zhuanzhuan operates as a goods trading unit of 58.com, which is recognized as China's largest online marketplace. The platform aims to enhance the trading experience by offering quality assurance services, thereby improving the usability and reliability of secondhand items for its customers.

OncoNano Medicine, Inc. is a biotechnology company focused on developing pH-activated compounds and nanotechnology-enabled fluorescent probes to enhance cancer surgery. Founded in 2014 and based in Southlake, Texas, the company aims to improve tumor visualization during surgical procedures by utilizing the variability of pH in diseased tissue. Its flagship program, ONM-100, specifically targets tumor acidosis, allowing for a clear distinction between cancerous and healthy tissues. This technology provides surgeons with the tools to excise tumors more accurately and manage cancer treatment effectively during and after surgery. OncoNano Medicine's innovative approach aims to enhance surgical outcomes and improve patient care in oncology.

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.

Boan Biotech is a fully integrated biopharmaceutical company specializing in the development, manufacture, and commercialization of therapeutic antibodies. The company focuses on several key therapeutic areas, including oncology, metabolism, autoimmunity, and ophthalmology. While it primarily generates revenue from customers in Mainland China, Boan Biotech aims to expand its reach globally. The company is committed to delivering high-quality biologics to address unmet medical needs in these critical fields.

Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.

Impelex Data Transfer Co., Ltd. is a system integration service provider based in Taichung, Taiwan, specializing in smart manufacturing solutions for the metal processing and hand tool production industries. Founded in 2013, the company focuses on forming strategic alliances to enhance operational efficiency and innovation in manufacturing processes.

Kaiyi Technology provides vehicles with assisted driving safety algorithms through image recognition, machine learning, and artificial intelligence. Focusing on the front-loading ADAS algorithm, it also designed an algorithm model for the aftermarket, providing the ADAS SDK for in-vehicle intelligent hardware, and implementing accurate ADAS functions on various hardware platforms, which will make greater contributions to the field of autonomous driving in the future.

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipeline in oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.

Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.

InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company specializes in targeted therapies, particularly for lung cancer, breast cancer, and gout. Its product pipeline includes small molecule drug candidates, such as D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor. InventisBio is also engaged in developing novel immuno-oncology therapies that can be used in conjunction with existing treatments like PD-1 antibodies for various cancer types. The company was co-founded by Dr. Yaolin Wang and other scientists with extensive experience in drug discovery at leading pharmaceutical firms, focusing on significant health challenges such as tumors and metabolic disorders.

AutoAI Technology Co., Ltd. is a Beijing-based company founded in 2018 that specializes in developing navigation technologies for connected vehicles. The company offers a comprehensive platform that integrates data and cloud services to enhance Internet accessibility within automobiles. Its product offerings include on-board components such as telematics boxes and a vehicle-optimized version of the Android operating system, alongside cloud-based technologies for data acquisition, storage, and analysis. Additionally, AutoAI provides various services to drivers, including entertainment, weather and traffic information, parking assistance, fueling options, and insurance services. As a subsidiary of NavInfo Co., Ltd., AutoAI also focuses on software solutions that incorporate artificial intelligence for dashboard functions, enhancing navigation, entertainment, voice control, and driver assistance in modern vehicles.

Emotibot Technologies Limited, founded in 2015 and based in Shanghai, specializes in developing artificial intelligence systems that enable robots to understand and respond to human emotions. The company offers a range of products, including personal bots, financial bots, and service bots, which utilize multi-modal emotion recognition and machine learning technologies. These systems facilitate human-like interactions through capabilities such as voice recognition, vision understanding, and affective computing. Emotibot's solutions cater to various sectors, including e-commerce, finance, smart devices, and call centers, enhancing user experience and operational efficiency by understanding customer intent and inquiries throughout the sales cycle. The company's innovative approach positions it as a significant player in the emotional intelligence and robotics field.

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipeline in oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.

Advantech Technologies Japan focuses on high-mix and small volume tailor-made embedded design-in services. The company was formerly known as OMRON Nohgata, a subsidiary of Omron Corporation, which was acquired by Advantech in 2018. ATJ is based in Nogata, Fukuoka, Japan.

Xiaozhu.com (小猪短租网) is a Chinese booking website for daily rental and short-term rooms. It aims to provide a guaranteed platform for online communication and transactions for landlords and tenants. Also, a green platform ecosystem is established by mechanisms such as property and personal safety guarantee schemes as well as identification. This will effectively take full advantages and maximize the value of landlords' idle resources through sharing. Meanwhile, it enhances the social relationship and interaction between landlords and tenants and provides tenants with more humanized accommodation experience which is different from traditional hotels. Currently, the company has had branches in 13 cities all over the country and its house sources cover more than 130 domestic cities.

Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.

Ideanomics is a multinational company based in New York that focuses on accelerating the commercialization of electric vehicles. The company operates through three main business units: Ideanomics Mobility, which specializes in electric vehicles including delivery trucks, vans, tractors, and two-wheelers; Ideanomics Energy, which provides charging and energy-related products and services; and Ideanomics Capital, which offers financing solutions for the Mobility and Energy sectors. The Mobile Energy Global (MEG) division under Ideanomics Mobility supports the adoption of electric vehicles among commercial fleet operators by offering vehicle procurement, financing, leasing, and energy management solutions. Together, these units aim to enhance transparency and efficiency for their customers, while also positioning shareholders to benefit from emerging growth industries. Ideanomics has a global presence with offices in Beijing, Hangzhou, and Qingdao, and operates in various regions including the U.S., China, Ukraine, and Malaysia.

Zhihu is a Chinese question-and-answer platform that distinguishes itself from traditional forums by encouraging users to share personal opinions and insights in response to inquiries. As of January 2012, the platform has amassed over 300,000 registered users. Zhihu operates primarily as an online content community and generates revenue through various channels, including paid membership services, advertising, content-commerce solutions, and vocational training. All of its revenue streams are derived from within China, reflecting its focus on the domestic market and its aim to foster a rich, interactive knowledge-sharing environment.

Sinovac Biotech Ltd. is a biopharmaceutical company based in Beijing, China, specializing in the research, development, manufacturing, and commercialization of vaccines for human infectious diseases. Its product portfolio includes vaccines for hepatitis A and B, seasonal influenza, H5N1 and H1N1 pandemic influenza, mumps, and enterovirus 71, which causes hand, foot, and mouth disease. Notable marketed products include Healive, an inactivated hepatitis A vaccine, and Panflu.1, a vaccine for H1N1 influenza, which was the first of its kind approved globally. Sinovac is also recognized as a key supplier of the H5N1 influenza vaccine for government stockpiling in China. The company is actively developing new vaccines, including those for pneumococcal diseases and rubella, with several in various stages of clinical trials. Sinovac collaborates with prominent institutions such as Peking University and the Chinese Academy of Medical Sciences, and it exports selected vaccines to countries like Mongolia, Nepal, and the Philippines. Founded in 1999, Sinovac plays a significant role in addressing public health needs in China and beyond.

Nanos Medical specializes in the research, development, manufacturing, and sales of disposable medical devices, primarily focusing on the cardiovascular and ENT (ear, nose, and throat) sectors. The company's product offerings include a range of interventional devices such as sinus balloon catheters, eustachian tube balloons, disposable nasopharyngeal airways, nasolacrimal balloons, and sinus drug-eluting stents. By providing these advanced medical devices, Nanos Medical aims to enhance treatment options for hospitals and improve patient care.

Alitek is a provider of Industrial automation solutions.

Qutoutiao Inc. is the No. 2 mobile content aggregator in China in terms of monthly average users (MAUs) and daily average users (DAUs). Their flagship mobile application, launched in June 2016, Qutoutiao, meaning “fun headlines” in Chinese, aggregates articles and short videos and presents customized feeds to users. These feeds are optimized in real time based on each user’s profile, behavior and social relationships through their proprietary AI-empowered content recommendation engine. They represent a new generation of technology-driven content platforms and their technology brings relevant information and entertainment to users, stimulates users’ desire to read, and ultimately improves the knowledge exchange in society. Their innovative user account system and gamified user loyalty program allows registered users to earn loyalty points by referring new users to register on Qutoutiao, by consuming content or by engaging on Qutoutiao. The gamified loyalty point system not only helps them keep users more engaged and enhance user stickiness, but also enables them to track users’ long-term behavior and optimize content recommendation.

Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.

KBP Biosciences is a biotechnology research and development organization focused on creating innovative therapies for unmet medical needs, particularly in the fields of cardiovascular, respiratory, inflammatory, and autoimmune diseases. The company specializes in the research, development, and commercialization of new medicines, leveraging its expertise in medicinal chemistry and clinical development. By addressing gaps in treatment options, KBP aims to provide healthcare providers with effective solutions for managing conditions that currently lack adequate therapies.

Biopharma company conducting clinical trials for cancer research.

Petuum, Inc. is a developer of a machine learning infrastructure platform that aims to make advanced artificial intelligence technology accessible and affordable for various enterprises. Founded in 2014 and based in Pittsburgh, Pennsylvania, the company has created the Petuum Operating System (PetuumOS), which serves as a flexible operating system and virtualization interface. This platform enables users to build, deploy, and manage machine learning and deep learning applications across diverse hardware environments, including data centers and Internet of Things devices. Additionally, Petuum offers solutions such as Petuum Poseidon, a framework for deep learning programming, and PetuumMed, a healthcare software system that provides comprehensive AI functionalities. By standardizing AI solutions, Petuum facilitates easier adoption of AI across industries, helping organizations achieve higher productivity, improved service, reduced costs, and faster delivery of applications.

Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.

Petuum, Inc. is a developer of a machine learning infrastructure platform that aims to make advanced artificial intelligence technology accessible and affordable for various enterprises. Founded in 2014 and based in Pittsburgh, Pennsylvania, the company has created the Petuum Operating System (PetuumOS), which serves as a flexible operating system and virtualization interface. This platform enables users to build, deploy, and manage machine learning and deep learning applications across diverse hardware environments, including data centers and Internet of Things devices. Additionally, Petuum offers solutions such as Petuum Poseidon, a framework for deep learning programming, and PetuumMed, a healthcare software system that provides comprehensive AI functionalities. By standardizing AI solutions, Petuum facilitates easier adoption of AI across industries, helping organizations achieve higher productivity, improved service, reduced costs, and faster delivery of applications.

Rokid is a Chinese technology company focused on artificial intelligence and robotics. The company develops and manufactures smart devices, including AI-powered smart speakers and augmented reality smart glasses, such as the Rokid Glass. These glasses utilize advanced technologies like facial recognition, language translation, and voice control to enhance user interaction by overlaying digital information onto the real world. Rokid's products leverage speech recognition, natural language processing, and image recognition to provide tailored experiences for consumers and enterprises, improving human-computer interaction and visual positioning capabilities. Through its innovative designs and technologies, Rokid aims to deliver superior user experiences across various industries.

TrustDecision, a fintech start-up based in Hangzhou, China, specializes in risk control services by offering online software solutions designed to combat theft and manage fraud. Founded in 2013, the company focuses on serving a range of sectors, including finance, insurance, payments, online shopping, and social networking. Through its innovative applications, TrustDecision aims to enhance security and mitigate risks for its clients in these industries.

Zai Lab Limited is a biopharmaceutical company based in Shanghai that focuses on discovering, developing, and commercializing innovative therapeutics for oncology, autoimmune, and infectious diseases. Founded in 2013, the company has established a diverse pipeline of proprietary drug candidates, including Niraparib for various solid tumors, Ripretinib for KIT and PDGFRa-driven cancers, and Margetuximab for breast and gastric cancers. Zai Lab also develops antibiotics such as Omadacycline and Durlobactam for bacterial infections. The company seeks to address unmet medical needs in China and globally by leveraging partnerships with leading biopharmaceutical firms and utilizing its in-house manufacturing capabilities. Zai Lab aims to establish itself as a fully integrated biopharmaceutical entity, enhancing its drug development efforts through collaborations with academic institutions and expanding its commercial reach in the Chinese market.

B+B SmartWorx designs and delivers connectivity and communication solutions tailored for various applications, focusing on intelligent machine-to-machine (M2M) and Internet of Things (IoT) connectivity. The company offers a range of products including Wzzard design and development kits, intelligent edge nodes, and 4G cellular Wi-Fi routers. Additionally, it provides Ethernet serial device servers, cables, Modbus gateways, protocol converters, as well as Ethernet switches, extenders, and routers. B+B SmartWorx aims to facilitate both wireless and wired network solutions, catering to diverse industry needs.

Advantech GPEG is a very different provider of display solutions provide specialized application displays, especially designing and producing intelligent displays for the gaming industry.

Innocore Gaming specializes in designing and manufacturing of hardware and software to the gaming industry. The company produces computer boards and other accessories for gaming applications.

DLoG GmbH develops robust and mobile industry computer solutions for applications in intra logistics, on large machines and in industrial manufacturing. Their industry computers prove themselves everywhere where visualizations are required under tough environmental or surrounding conditions.